ProCE Banner Series

Discover the Path Forward for Patients With ESR1m ER+/HER2- mBC Following Progression on Endocrine Therapy

Key Takeaways:

  • Test for ESR1 mutation
    • Benefit of liquid biopsies to detect acquired ESR1m upon 1L progression, and any subsequent progression
    • Causes and implications of the ESR1m as a driver of progression in ER+/HER2- mBC
  • Treat with ORESERD
    • ORSERDU efficacy and safety data to optimize patient management

All Events

Discover the Path Forward for Patients With ESR1m ER+/HER2- mBC Following Progression on Endocrine Therapy

Upcoming Events

May

21

2025

12:15 PM - 12:45 PM Central Time (CT)

Virtual

Acknowledgement

Sponsored By

Stemline